Tecan Group AG (LTS:0QLN)
CHF 176.73 -1.1234 (-0.63%) Market Cap: 2.24 Bil Enterprise Value: 2.15 Bil PE Ratio: 0 PB Ratio: 1.94 GF Score: 73/100

Tecan Group AG at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 03:30PM GMT
Release Date Price: CHF158.05 (-1.46%)
Artem Savchenko
JP Morgan Asset Management - Analyst

Good morning, everyone. Happy to see you all. My name is Artem, and welcome you all at Tecan Company presentation at 44th JPMorgan Healthcare Conference. The presentation will be led by the CEO of the company, Monica Manotas. And we're targeting for 30 minutes presentation and 10 minutes Q&A at the end. So save your questions until the end of the presentation. The Q&A will be joined by the CFO of the company, Tania Micki.

Monica, over to you.

Monica Manotas
Tecan Group AG - Chief Executive Officer, Director

Thank you, Artem. So good morning, everyone. First of all, thank you very much for joining. I appreciate your interest in Tecan, and I'm excited to be here to tell you the story. Before I get into the material, just say a word about myself.

I've been in the seat for about five months now, so still relatively new to it, but certainly not new to the life sciences tool space. I've been in the industry for over 25 years. And my story with Tecan started actually quite a few years

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot